Patents by Inventor Nisar Asmed Khan

Nisar Asmed Khan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene regulator
    Publication number: 20110105415
    Abstract: The invention relates to the modulation of gene expression in a cell, also called gene control, in particular in relation to the treatment of a variety of diseases. The invention provides a method for modulating expression of a gene in a cell comprising providing the cell with a signalling molecule comprising a peptide or functional analogue thereof. Furthermore, the invention provides a method for identifying or obtaining a signalling molecule comprising a peptide or functional derivative or analogue thereof capable of modulating expression of a gene in a cell comprising providing the cell with a peptide or derivative or analogue thereof and determining the activity and/or nuclear translocation of a gene transcription factor.
    Type: Application
    Filed: April 14, 2009
    Publication date: May 5, 2011
    Applicant: Biotempt B.V.
    Inventors: Nisar Asmed Khan, Robert Benner
  • Gene regulator
    Publication number: 20080176243
    Abstract: The invention relates to the modulation of gene expression in a cell, also called gene control, in particular in relation to the treatment of a variety of diseases. The invention provides a method for modulating expression of a gene in a cell comprising providing the cell with a signalling molecule comprising a peptide or functional analogue thereof. Furthermore, the invention provides a method for identifying or obtaining a signalling molecule comprising a peptide or functional derivative or analogue thereof capable of modulating expression of a gene in a cell comprising providing the cell with a peptide or derivative or analogue thereof and determining the activity and/or nuclear translocation of a gene transcription factor.
    Type: Application
    Filed: December 6, 2007
    Publication date: July 24, 2008
    Applicant: Biotempt. B.V.
    Inventors: Nisar Asmed Khan, Robert Benner
  • Oligopeptide treatment of NF-?B mediated inflammation
    Patent number: 7175679
    Abstract: The invention relates to the modulation of gene expression in a cell, also called gene control, in particular in relation to the treatment of anthrax. The invention provides a method for modulating expression of a gene in a cell comprising providing the cell with a signaling molecule comprising a peptide or functional analogue thereof.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: February 13, 2007
    Assignee: Biotempt B.V.
    Inventors: Nisar Asmed Khan, Robert Benner
  • Gene regulator
    Publication number: 20030113733
    Abstract: The invention relates to the modulation of gene expression in a cell, also called gene control, in particular in relation to the treatment of a variety of diseases. The invention provides a method for modulating expression of a gene in a cell comprising providing said cell with a signalling molecule comprising a peptide or functional analogue thereof. Furthermore, the invention provides a method for identifying or obtaining a signalling molecule comprising a peptide or functional derivative or analogue thereof capable of modulating expression of a gene in a cell comprising providing said cell with a peptide or derivative or analogue thereof and determining the activity and/or nuclear translocation of a gene transcription factor.
    Type: Application
    Filed: December 21, 2001
    Publication date: June 19, 2003
    Inventors: Nisar Asmed Khan, Robert Benner